FDA Approves Inamed’s Gel to Treat Wrinkles
- Share via
Inamed Corp. of Santa Barbara won Food and Drug Administration approval for Captique, an injectable gel to combat facial wrinkles. The product uses hyaluronic acid, a substance that naturally occurs in skin, to plump out wrinkles.
Inamed’s first-generation hyaluronic gel, Hylaform, was made from ground rooster combs. Captique does not contain animal products. The gels compete with Medicis Pharmaceutical Corp.’s Restylane and are alternatives to collagen, Inamed’s mainstay wrinkle treatment.
Captique will be manufactured by Genzyme Corp. of Cambridge, Mass., and marketed by Inamed. Inamed shares rose $1.58 to $56.95 on Nasdaq.
*
-- Denise Gellene
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
